MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?
Condition(s):NeoplasmsLast Updated:October 18, 2023Completed
Hide Studies Not Open or Pending
Condition(s):NeoplasmsLast Updated:October 18, 2023Completed
Condition(s):Alzheimer Disease; MCI; AgingLast Updated:April 3, 2019Unknown status
Condition(s):Von Willebrand Disease, Type 2BLast Updated:August 24, 2022Unknown status
Condition(s):Multiple SclerosisLast Updated:February 18, 2021Unknown status
Condition(s):Sarcoma, Soft Tissue; Osteosarcoma TumorLast Updated:August 21, 2015Unknown status
Condition(s):Mild Cognitive Impairment; DementiaLast Updated:March 8, 2024Active, not recruiting
Condition(s):Glaucoma; Mild Cognitive Impairment; Glaucoma and Mild Cognitive Impairment; HealthyLast Updated:February 19, 2018Unknown status
Condition(s):Social CognitionLast Updated:January 5, 2021Unknown status
Condition(s):Parkinson Disease; Multiple SclerosisLast Updated:September 30, 2021Completed
Condition(s):Neuropsychology; GestureLast Updated:August 9, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.